RELVAR(R) ELLIPTA(R) Receives European Marketing Authorisation for the

RELVAR(R) ELLIPTA(R) Receives European Marketing Authorisation for the
COPD: the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD) with a FEV1 < 70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy. Relvar is …. decrease in bone … Read more on EIN News (press release)

Alcohol use 'masks' quake troubles
People in their late 30s and early 40s were requiring treatment for alcohol-related illnesses including chronic liver disease, she said. Since the quakes, the … "We suspect that alcohol is masking depression and anxiety and general low mood. "Alcohol … Read more on The Press

Oru vadakan veeraghatha…comedy skit
Story,script&direction…Shaju Meleveettil…Kuwait.